首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC β-Lactamase in P. mirabilis
【2h】

Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC β-Lactamase in P. mirabilis

机译:临床分离的奇异变形杆菌中的KPC-2的检测以及首次报道的由奇异变形杆菌中KPCβ-内酰胺酶引起的碳青霉烯酶耐药性的描述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An isolate of Proteus mirabilis recovered from blood cultures of a diabetic patient was shown to be resistant to imipenem, meropenem, and ertapenem by disk diffusion susceptibility testing. Amplification of whole-cell and/or plasmid DNA recovered from the isolate with primers specific for the blaKPC carbapenemase gene produced an amplicon of the expected size which was confirmed to be blaKPC-2 by sequence analysis. Transformation of a susceptible Escherichia coli host with plasmid preparations from the isolate generated a transformant for which the MICs of all of the carbapenems tested were increased three- to fourfold. We believe this to be the first report of carbapenem resistance in P. mirabilis caused by the acquisition of blaKPC.
机译:从糖尿病患者的血液培养物中回收的变形杆菌变形杆菌通过磁盘扩散敏感性测试显示对亚胺培南,美洛培南和厄他培南具有抗性。用对blaKPC碳青霉烯酶基因具有特异性的引物扩增从分离物中回收的全细胞和/或质粒DNA,产生了预期大小的扩增子,通过序列分析证实该扩增子为blaKPC-2。用来自分离物的质粒制备物转化易感的大肠杆菌宿主产生了转化子,对于该转化子,所有测试的碳青霉烯的MIC均增加了三到四倍。我们认为,这是收购blaKPC引起的奇异假单胞菌对碳青霉烯类药物的首次报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号